Forbes: This startup wants to make fitness accessible for all
UC alumnus Ryan Eder's inclusive health and wellness platform continues to gain traction
Startups pivot. It happens all the time. Plenty of companies have canned their original ideas in order to go in a different direction entirely.
But for Ohio-based IncludeHealth, its shift has only deepened its commitment to its original mission — accessible fitness for all — even though it’s found a totally new home in software and data analytics instead.
For founder and CEO Ryan Eder, it’s also a show of persistence — IncludeHealth has been a nearly 14-year journey that started during his senior year of college at the University of Cincinnati. Now, the company is working with Cincinnati Children’s Hospital Medical Center in a partnership that could take musculoskeletal care to the next level.
And that’s only the most recent bit of news.
“For me, my primary driver through all this has been to help people,” the alumnus told Forbes. “If you’re not solving a problem and helping others, what’s the point?”
Related Stories
UC's art collection on display at the Contemporary Arts Center
January 5, 2026
University of Cincinnati leaders joined WVXU's Cincinnati Edition to talk about the university’s 200-year-old art collection, a new exhibition at the Contemporary Arts Center and the release of a companion book exploring the collection’s role in education and public engagement.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.